Enzymatic formation of prostamide F2α from anandamide involves a newly identified intermediate metabolite, prostamide H2

Prostaglandin F2α 1-ethanolamide (prostamide F2α) is a potent ocular hypotensive agent in animals and represents a new class of fatty acid amide compounds. Accumulated evidence indicated that anandamide, an endogenous bioactive ligand for cannabinoid receptors, may serve as a common substrate to pro...

Full description

Bibliographic Details
Main Authors: Wu Yang, Jinsong Ni, David F. Woodward, Diane D-S. Tang-Liu, Kah-Hiing John Ling
Format: Article
Language:English
Published: Elsevier 2005-12-01
Series:Journal of Lipid Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0022227520328637
_version_ 1818715717313232896
author Wu Yang
Jinsong Ni
David F. Woodward
Diane D-S. Tang-Liu
Kah-Hiing John Ling
author_facet Wu Yang
Jinsong Ni
David F. Woodward
Diane D-S. Tang-Liu
Kah-Hiing John Ling
author_sort Wu Yang
collection DOAJ
description Prostaglandin F2α 1-ethanolamide (prostamide F2α) is a potent ocular hypotensive agent in animals and represents a new class of fatty acid amide compounds. Accumulated evidence indicated that anandamide, an endogenous bioactive ligand for cannabinoid receptors, may serve as a common substrate to produce all prostamides, including prostamide F2α. After incubation of anandamide with cyclooxygenase 2 (COX-2), the reaction mixture was profiled by HPLC and an intermediate metabolite was discovered and characterized as a cyclic endoperoxide ethanolamide using HPLC-tandem mass spectrometry. Formation of prostamide F2α was also demonstrated when the intermediate metabolite was isolated and incubated with prostaglandin F synthase (PGF synthase).These results suggest that the biosynthesis of prostamide F2α proceeds in two consecutive steps: oxidation of anandamide to form an endoperoxide intermediate by COX-2, and reduction of the endoperoxide intermediate to form prostamide F2α by PGF synthase. This endoperoxide ethanolamide intermediate has been proposed as prostamide H2.
first_indexed 2024-12-17T19:07:48Z
format Article
id doaj.art-d12733577f7d48708722338bd31fdeec
institution Directory Open Access Journal
issn 0022-2275
language English
last_indexed 2024-12-17T19:07:48Z
publishDate 2005-12-01
publisher Elsevier
record_format Article
series Journal of Lipid Research
spelling doaj.art-d12733577f7d48708722338bd31fdeec2022-12-21T21:35:57ZengElsevierJournal of Lipid Research0022-22752005-12-01461227452751Enzymatic formation of prostamide F2α from anandamide involves a newly identified intermediate metabolite, prostamide H2Wu Yang0Jinsong Ni1David F. Woodward2Diane D-S. Tang-Liu3Kah-Hiing John Ling4To whom correspondence should be addressed.; Department of Pharmacokinetics and Drug Metabolism, Allergan, Inc., Irvine, CA 92623Department of Pharmacokinetics and Drug Metabolism, Allergan, Inc., Irvine, CA 92623Department of Biological Sciences, Allergan, Inc., Irvine, CA 92623Department of Pharmacokinetics and Drug Metabolism, Allergan, Inc., Irvine, CA 92623Department of Pharmacokinetics and Drug Metabolism, Allergan, Inc., Irvine, CA 92623Prostaglandin F2α 1-ethanolamide (prostamide F2α) is a potent ocular hypotensive agent in animals and represents a new class of fatty acid amide compounds. Accumulated evidence indicated that anandamide, an endogenous bioactive ligand for cannabinoid receptors, may serve as a common substrate to produce all prostamides, including prostamide F2α. After incubation of anandamide with cyclooxygenase 2 (COX-2), the reaction mixture was profiled by HPLC and an intermediate metabolite was discovered and characterized as a cyclic endoperoxide ethanolamide using HPLC-tandem mass spectrometry. Formation of prostamide F2α was also demonstrated when the intermediate metabolite was isolated and incubated with prostaglandin F synthase (PGF synthase).These results suggest that the biosynthesis of prostamide F2α proceeds in two consecutive steps: oxidation of anandamide to form an endoperoxide intermediate by COX-2, and reduction of the endoperoxide intermediate to form prostamide F2α by PGF synthase. This endoperoxide ethanolamide intermediate has been proposed as prostamide H2.http://www.sciencedirect.com/science/article/pii/S0022227520328637cyclooxygenase 2prostaglandin F2α 1-ethanolamideprostaglandin F synthase
spellingShingle Wu Yang
Jinsong Ni
David F. Woodward
Diane D-S. Tang-Liu
Kah-Hiing John Ling
Enzymatic formation of prostamide F2α from anandamide involves a newly identified intermediate metabolite, prostamide H2
Journal of Lipid Research
cyclooxygenase 2
prostaglandin F2α 1-ethanolamide
prostaglandin F synthase
title Enzymatic formation of prostamide F2α from anandamide involves a newly identified intermediate metabolite, prostamide H2
title_full Enzymatic formation of prostamide F2α from anandamide involves a newly identified intermediate metabolite, prostamide H2
title_fullStr Enzymatic formation of prostamide F2α from anandamide involves a newly identified intermediate metabolite, prostamide H2
title_full_unstemmed Enzymatic formation of prostamide F2α from anandamide involves a newly identified intermediate metabolite, prostamide H2
title_short Enzymatic formation of prostamide F2α from anandamide involves a newly identified intermediate metabolite, prostamide H2
title_sort enzymatic formation of prostamide f2α from anandamide involves a newly identified intermediate metabolite prostamide h2
topic cyclooxygenase 2
prostaglandin F2α 1-ethanolamide
prostaglandin F synthase
url http://www.sciencedirect.com/science/article/pii/S0022227520328637
work_keys_str_mv AT wuyang enzymaticformationofprostamidef2afromanandamideinvolvesanewlyidentifiedintermediatemetaboliteprostamideh2
AT jinsongni enzymaticformationofprostamidef2afromanandamideinvolvesanewlyidentifiedintermediatemetaboliteprostamideh2
AT davidfwoodward enzymaticformationofprostamidef2afromanandamideinvolvesanewlyidentifiedintermediatemetaboliteprostamideh2
AT dianedstangliu enzymaticformationofprostamidef2afromanandamideinvolvesanewlyidentifiedintermediatemetaboliteprostamideh2
AT kahhiingjohnling enzymaticformationofprostamidef2afromanandamideinvolvesanewlyidentifiedintermediatemetaboliteprostamideh2